ClinicalTrials.Veeva

Menu
A

Atria Clinical Research | Little Rock, AR

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Risankizumab
Troriluzole
IW-3718
Cariprazine
Brexpiprazole
TRx0237
BI 425809
Vupanorsen
Levothyroxine

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 12 total trials

A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease (FORTIFY)

The study consists of 4 sub-studies, as follows:* Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safet...

Active, not recruiting
Crohn's Disease
Drug: Placebo for Risankizumab IV
Drug: Risankizumab SC

The study's purpose is to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compul...

Enrolling
Obsessive-Compulsive Disorder
Drug: Placebo
Drug: Troriluzole

The purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compuls...

Invitation-only
Obsessive Compulsive Disorder
Drug: Troriluzole (BHV-4157)

Trial sponsors

AbbVie logo
Biohaven logo
Allergan logo
Boehringer Ingelheim logo
Ironwood Pharmaceuticals logo
N
Otsuka logo
Pfizer logo
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems